Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double umbilical cord blood transplantation in high-risk hematological patients
2012-001188-55Phase 2Active
- Sponsor
- HOVON
- Start
- Jun 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cord blood unit in hematopoietic malignancies, sponsored by HOVON. Primary endpoint: Activated class II-specific T-cells. Started Jun 2012; status: active.
02
Drugs
cord blood unit
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on 2012-001188-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001188-55.